Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma
Authors:
- Mitsuo HoriMHMitsuo Hori
- Yasushi OkoshiYOYasushi Okoshi
- Fumie FujisawaFFFumie Fujisawa
- Atsushi ShinagawaASAtsushi Shinagawa
- Daisuke KudoDKDaisuke Kudo
- Takuya KomenoTKTakuya Komeno
- Chikashi YoshidaCYChikashi Yoshida
- Yukitaka KatsuraYKYukitaka Katsura
- Ikuyo OtaIOIkuyo Ota
- Seiichi ShimizuSSSeiichi Shimizu
- Masaharu KamoshitaMKMasaharu Kamoshita
- 3 April 2015
- journal article
- clinical trial
- Published by S. Karger AG in Acta Haematologica
- Vol. 134 (1) , 25-31